|
NKAP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.195600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.721800E-03 |
| Normal-vs-Stage2 |
5.665400E-01 |
| Normal-vs-Stage3 |
1.859150E-01 |
| Normal-vs-Stage4 |
7.495000E-01 |
| Stage1-vs-Stage2 |
6.438800E-01 |
| Stage1-vs-Stage3 |
6.798100E-03 |
| Stage1-vs-Stage4 |
3.760000E-01 |
| Stage2-vs-Stage3 |
1.738010E-01 |
| Stage2-vs-Stage4 |
8.476400E-01 |
| Stage3-vs-Stage4 |
2.973200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.598000E-02 |
| Normal-vs-AfricanAmerican |
3.474400E-01 |
| Normal-vs-Asian |
8.946600E-01 |
| Caucasian-vs-AfricanAmerican |
6.426600E-01 |
| Caucasian-vs-Asian |
4.730600E-01 |
| AfricanAmerican-vs-Asian |
6.291400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.206100E-04 |
| Normal-vs-Female |
1.146360E-02 |
| Male-vs-Female |
9.0724999735059E-09 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.420400E-01 |
| Normal-vs-Extreme_Weight |
2.982700E-03 |
| Normal-vs-Obese |
7.716400E-01 |
| Normal-vs-Extreme_Obese |
1.228230E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.870100E-02 |
| Normal_Weight-vs-Obese |
4.673200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.902800E-01 |
| Extreme_Weight-vs-Obese |
1.184430E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.175400E-01 |
| Obese-vs-Extreme_Obese |
1.861190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.353700E-02 |
| Normal-vs-Age(41-60Yrs) |
5.007400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.878660E-03 |
| Normal-vs-Age(81-100Yrs) |
3.681800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.040100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.186900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.892400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.539500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.169800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.329000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.427810E-02 |
| Normal-VS-Type2 PRCC |
1.414420E-01 |
| Normal-VS-KIRP CIMP |
2.909600E-02 |
| Normal-VS-Unclassified PRCC |
3.893000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.758200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.15559999999981E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.599600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.699560E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.497200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.715700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.282400E-02 |
| Normal-vs-N1 |
1.536960E-01 |
| Normal-vs-N2 |
4.395700E-02 |
| N0-vs-N1 |
4.119500E-03 |
| N0-vs-N2 |
4.688400E-02 |
| N1-vs-N2 |
7.239200E-01 |
|
|
